BCDA (BCDA) Stock Price & Analysis
BCDA (BCDA) rose 0.00% to USD 0.85 as of July 25, 2026 at 04:48 UTC, according to Nexqual real-time market data.
BCDA last closed at USD 0.85; the session ranged USD 0.85–0.91 on volume of 124,824 shares. Market capitalization is —, with a 52-week range of USD 0.78–2.4 (NCM). Source: Nexqual, July 25, 2026 at 04:48 UTC.
Key Statistics (as of July 25, 2026 at 04:48 UTC)
| Price | USD 0.85 |
|---|---|
| Change | ▲ 0.00% (up) |
| Previous Close | USD 0.85 |
| Open | USD 0.85 |
| Day Range | USD 0.85 – 0.91 |
| 52-Week Range | USD 0.78 – 2.4 |
| Volume | 124,824 shares |
| Market Cap | — |
| Exchange | NCM |
Technical Analysis (BCDA)
Nexqual's technical model rates BCDA "SELL" based on 1 bullish and 5 bearish signals across 125 daily candles, as of July 25, 2026 at 04:48 UTC.
| Overall Signal | SELL |
|---|---|
| RSI (14) | 40.26 (neutral) |
| vs SMA50 | Below (USD 0.96) |
| MACD | -0.04 (negative) |
From BCDA's Latest SEC 10-K Filing (filed 2026-03-24)
Source: SEC EDGAR 10-K. Curated by Nexqual.
Peers & Related Stocks
| Symbol | Name | Price | Change |
|---|---|---|---|
| ADIL | Adial Pharmaceuticals, Inc | USD 2.78 | ▲ 2.96% |
| ENSC | Ensysce Biosciences, Inc. | USD 0.26 | ▼ 7.96% |
| NMAD | Nomad Power Solutions, Inc. | USD 4.84 | ▼ 3.01% |
| PHIO | Phio Pharmaceuticals Corp. | USD 1.04 | ▼ 1.89% |
| ARDS | Aridis Pharmaceuticals Inc. | USD 0 | ▲ 0% |
Data source: Nexqual — real-time market data, technical indicators, analyst consensus, earnings, SEC EDGAR filings. Last updated: July 25, 2026 at 04:48 UTC. This page is informational and not investment advice.